References
- WHO. Hepatitis E 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-e
- Kamar N, Izopet J, Pavio N, et al. Hepatitis E virus infection. Nat Rev Dis Primers. 2017;3:17086.
- Desai AN. Hepatitis E. JAMA. 2020;323(18):1862.
- Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014;370(23):2211–2218.
- Bergløv A, Hallager S, Weis N. Hepatitis E during pregnancy: maternal and foetal case-fatality rates and adverse outcomes – a systematic review. J Viral Hepat. 2019;26(11):1240–1248.
- Bigna JJ, Modiyinji AF, Nansseu JR, et al. Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2020;20(1):426.
- Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376(9744):895–902.
- Zhang J, Shih JW, Xia NS. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015;372(23):2265–2266.
- Wu T, Zhu F-C, Huang S-J, et al. Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Hepatology. 2012;55(6):2038.
- WHO. Human papillomavirus vaccines: WHO position paper; 2022. Available from: https://apps.who.int/iris/handle/10665/365351
- Zhao F-H, Wu T, Hu Y-M, et al. Efficacy, safety, and immunogenicity of an Escherichia coli-produced human papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial. Lancet Infect Dis. 2022;22(12):1756–1768.
- Qiao YL, Wu T, Li RC, et al. Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial. J Natl Cancer Inst. 2020;112(2):145–153.
- PATH. New HPV vaccine from Innovax receives WHO prequalification 2021. Available from: https://www.path.org/media-center/new-hpv-vaccine-innovax-receives-who-prequalification/
- Zhuang CL, Lin ZJ, Bi ZF, et al. Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response. Emerg Microbes Infect. 2021;10(1):365–375.
- Skipetrova A, Wartel TA, Gailhardou S. Dengue vaccination during pregnancy - An overview of clinical trials data. Vaccine. 2018;36(23):3345–3350.
- Abortion WGotCECotDaToS. Chinese experts consensus on the diagnosis and treatment of spontaneous abortion. Chin J Practical Gynecol Obstet. 2020;36(11):1082–1090.
- WHO. Preterm birth 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/preterm-birth
- CDC. Birth defects surveillance toolkit. Available from: https://www.cdc.gov/ncbddd/birthdefects/surveillancemanual/chapters/chapter-1/chapter1-4.html
- CDC. Pregnancy complications 2020. Available from: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pregnancy-complications.html
- WHO. HPV vaccination dashboard. Available from: https://app.powerbi.com/view?r=eyJrIjoiNDIxZTFkZGUtMDQ1Ny00MDZkLThiZDktYWFlYTdkOGU2NDcwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9
- Kharbanda EO, Vazquez-Benitez G, DeSilva MB, et al. Association of inadvertent 9-valent human papillomavirus vaccine in pregnancy with spontaneous abortion and adverse birth outcomes. JAMA Netw Open. 2021;4(4):e214340.
- Scheller NM, Pasternak B, Molgaard-Nielsen D, et al. Quadrivalent HPV vaccination and the risk of adverse pregnancy outcomes. N Engl J Med. 2017;376(13):1223–1233.
- Panagiotou OA, Befano BL, Gonzalez P, et al. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV vaccine trial. Br Med J. 2015;351:h4358.
- Zeng Y, Hesketh T. The effects of China’s universal two-child policy. Lancet (London, England). 2016;388(10054):1930–1938.
- Hu CY, Yang XJ, Hua XG, et al. Risk factors for spontaneous abortion from a prevention perspective in rural China: a population-based follow-up study. J Matern Fetal Neonatal Med. 2021;34(16):2583–2591.
- Zhao Y, Zhao Y, Fan K, et al. Association of history of spontaneous or induced abortion with subsequent risk of gestational diabetes. JAMA Netw Open. 2022;5(3):e220944.
- Zhou LY, Zhang HX, Lan YL, et al. Epidemiological investigation of risk factors of the pregnant women with early spontaneous abortion in Beijing. Chin J Integr Med. 2017;23(5):345–349.
- Rao J, Fan D, Wu S, et al. Trend and risk factors of low birth weight and macrosomia in south China, 2005-2017: a retrospective observational study. Sci Rep. 2018;8(1):3393.
- Deng K, Liang J, Mu Y, et al. Preterm births in China between 2012 and 2018: an observational study of more than 9 million women. Lancet Glob Health. 2021;9(9):e1226–e1241.
- Luo J, Fan C, Luo M, et al. Pregnancy complications among nulliparous and multiparous women with advanced maternal age: a community-based prospective cohort study in China. BMC Pregnancy Childbirth. 2020;20(1):581.
- Munoz FM, Jamieson DJ. Maternal immunization. Obstet Gynecol. 2019;133(4):739–753.
- CDC. Guidelines for vaccinating pregnant women. Available from: https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/guidelines.html#hepb
- Groom HC, Irving SA, Koppolu P, et al. Uptake and safety of hepatitis B vaccination during pregnancy: a vaccine safety datalink study. Vaccine. 2018;36(41):6111–6116.
- Moro PL, Zheteyeva Y, Barash F, et al. Assessing the safety of hepatitis B vaccination during pregnancy in the vaccine adverse event reporting system (VAERS), 1990-2016. Vaccine. 2018;36(1):50–54.
- Nassar AH, Visser GHA, Nicholson WK, et al. FIGO statement: vaccination in pregnancy. Int J Gynaecol Obstet. 2021;152(2):139–143.
- Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(2):198–206.
- Xia R, Sun S, Shen M, et al. Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China. Vaccine. 2019;37(39):5868–5876.
- Zhao Y, Zhang X, Zhu F, et al. A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions. Hum Vaccin Immunother. 2016;12(8):2003–2009.
- Ciglenecki I, Rumunu J, Wamala JF, et al. The first reactive vaccination campaign against hepatitis E. Lancet Infect Dis. 2022;22(8):1110–1111.